ESGV vs IBB
Vanguard ESG US Stock ETF vs iShares Biotechnology ETF
- • ESGV has the lower expense ratio at 0.09% vs 0.44% for IBB.
- • ESGV pays a higher dividend yield (0.87%).
Side-by-side metrics
| Metric | ESGV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.87% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $13.18B | $9.09B |
YTD return | 9.48% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.13 | 0.69 |
P/E ratio | 26.89 | 24.89 |
Last price | $133.30 | $197.34 |
Inception | — | — |
Issuer | Vanguard | iShares |
ESGV top holdings
| NVDA | NVIDIA Corp | 8.36% |
| AAPL | Apple Inc | 7.60% |
| MSFT | Microsoft Corp | 5.65% |
| AMZN | Amazon.com Inc | 4.39% |
| GOOGL | Alphabet Inc Class A | 3.74% |
| AVGO | Broadcom Inc | 3.49% |
| GOOG | Alphabet Inc Class C | 3.01% |
| META | Meta Platforms Inc Class A | 2.34% |
| TSLA | Tesla Inc | 2.08% |
| MU | Micron Technology Inc | 1.84% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About ESGV
ESGV (Vanguard ESG US Stock ETF) is Broad US market with ESG screens applied. Managed by Vanguard, the fund carries $13.2B in assets under management, an expense ratio of 0.09%, a dividend yield of 0.87%. Its largest holding is NVIDIA Corp (NVDA), which represents 8.4% of the portfolio. Real Estate is the fund's largest sector exposure at 2.6%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.